Previous Article | Next Article ![]()
Molecular and Cellular Biology, March 1999, p. 1910-1918, Vol. 19, No. 3
Laboratory of Molecular Immunology, National
Heart, Lung, and Blood Institute, National Institutes of Health,
Bethesda, Maryland 20892-1674,1 and
Laboratories of Molecular Cell
Biology2 and Molecular
Biophysics,3 The Rockefeller University, New
York, New York 10021
Received 18 September 1998/Returned for modification 3 November
1998/Accepted 17 November 1998
Stat5a and Stat5b are rapidly activated by a wide range of
cytokines and growth factors, including interleukin-2 (IL-2). We have
previously shown that these signal transducers and activators of
transcription (STAT proteins) are key regulatory proteins that bind to
two tandem gamma interferon-activated site (GAS) motifs within an IL-2
response element (positive regulatory region III [PRRIII]) in the
human IL-2R The interaction of interleukin-2
(IL-2) with high-affinity IL-2 receptors critically regulates the
magnitude and duration of the T-cell immune response (17).
In peripheral blood lymphocytes (PBL), IL-2 rapidly activates the
Janus-family tyrosine kinases Jak1 and Jak3 (1, 2, 14, 22, 26,
33) and the latent STAT (signal transducers and activators of
transcription) transcription factors Stat3, Stat5a, and Stat5b
(5-7, 10, 18, 19, 25, 32). The STAT proteins then homo- or
heterodimerize and translocate to the nucleus, where they bind to and
regulate the transcriptional activation of the promoters of target genes.
Dimeric STAT proteins can bind to the palindromic gamma
interferon-activated (GAS) sequence TTCNmGAA, where m is 3 for all the STATs except Stat6, which can additionally bind to GAS
motifs where m is 4 (reviewed in references 3, 4,
11, and 16). However, there are
differences in the fine DNA binding specificities for the various STAT
proteins; binding site specificity studies have identified specific
nucleotide requirements in the three central nucleotides and in the
sequences flanking the core consensus sequence of the different STAT
proteins (8, 21, 27, 28, 36).
It has also been shown that, in addition to binding to DNA as dimers,
Stat1 and Stat4 can form tetrameric complexes on tandemly linked GAS
motifs and that tetramer formation is mediated by the highly conserved
N-terminal regions (N domains) of these proteins (30, 35).
Such cooperative DNA binding can serve to selectively bind different
STAT proteins on a promoter that contains multiple potential STAT
binding sites (35). Recently, the crystal structure of the N
domain of Stat4 was determined to be a hook-like structure consisting
of eight In this study, we investigated the importance and molecular basis of
N-domain-mediated tetramerization of Stat5 in regulating the
transcriptional activation of a complex, natural promoter element
containing tandem GAS motifs. Stat5 proteins are key signaling molecules that are activated by a variety of different cytokines and
growth factors, including IL-2 (16). One important target gene regulated by Stat5 encodes the highly IL-2-inducible component of
the IL-2 receptor (IL-2R) complex itself, the IL-2R
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Significance of Tetramerization in Promoter Recruitment
by Stat5


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
promoter. In this study, we demonstrate cooperative
binding of Stat5 to PRRIII and explore the molecular basis underlying
this cooperativity. We demonstrate that formation of a tetrameric Stat5
complex is essential for the IL-2-inducible activation of PRRIII.
Stable tetramer formation of Stat5 is mediated through protein-protein
interactions involving a tryptophan residue conserved in all STATs and
a lysine residue in the Stat5 N-terminal domain (N domain). The
functional importance of tetramer formation is shown by the decreased
levels of transcriptional activation associated with mutations in these
residues. Moreover, the requirement for STAT protein-protein
interactions for gene activation from a promoter with tandemly linked
GAS motifs can be relieved by strengthening the avidity of protein-DNA
interactions for the individual binding sites. Taken together, these
studies demonstrate that a dimeric but tetramerization-deficient Stat5
protein can activate only a subset of target sites. For functional
activity on a wider range of potential recognition sites,
N-domain-mediated oligomerization is essential.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
-helices (31). A tryptophan residue, conserved in all STATs, was shown to be engaged in crucial internal polar interactions between interacting helices in the structure. Mutation of
this residue in Stat1 prevented tetramer formation and, consequently, resulted in the loss of gamma interferon-inducible transcriptional activity from a synthetic, model promoter. These results established the importance of this tryptophan residue in the functional activity of
Stat1 and suggested that this residue would be important for tetramer
formation by other STATs as well.
chain (12,
13, 15, 23, 29). An IL-2 response element (positive regulatory
region III [PRRIII]) (Fig. 1A) was
identified in both murine and human IL-2R
genes (13, 15,
29). In the human IL-2R
gene, PRRIII is located 3.7 kb
upstream of the transcription initiation sites and is a complex element
composed of two GAS motifs bound by Stat5, as well as binding sites for
other factors, including the Ets-family protein Elf-1, the
high-mobility-group proteins, HMG-I(Y), and a putative GATA-like factor
(13, 29). The two GAS motifs are linked in tandem; one is a
consensus GAS motif (GASc), while the other is a
nonconsensus GAS motif (GASn) (Fig. 1A). Full functional
activity of PRRIII is dependent on the simultaneous presence of both of
the GAS motifs and the downstream Elf-1 binding site (13).
Recently, studies of the murine IL-2R
IL-2 response element
suggested that responsiveness of this element to IL-2 is mediated by
cooperative interactions between Stat5 dimers bound to the tandem GAS
motifs (20). Based on the information available on the
crystal structure of N-terminal dimers of Stat4, we generated putative
N-terminal oligomerization mutants of Stat5 and directly demonstrated
the importance of N-terminal oligomerization of Stat5 proteins in
mediating the IL-2-inducible activation of a naturally occurring
promoter element, PRRIII. In so doing, we have also learned more about
the requirements for Stat5 tetramerization and Stat5-dependent
transcriptional activation.

View larger version (28K):
[in a new window]
FIG. 1.
Stat5 binds to tandem GAS motifs in PRRIII. (A) Sequence
and organization of PRRIII. Also shown are the sequences of the probes
used for the EMSAs depicted in panel B. EBS, Ets binding site. (B)
Stat5 binds efficiently only to probes containing both of the GAS
motifs. EMSAs were performed with nuclear extracts derived from normal
preactivated PBL that were either unstimulated (lanes 1, 3, 5, and 7)
or stimulated with 2 nM IL-2 (lanes 2, 4, 6, and 8) for 30 min. The
inducible complex, which we have previously shown to contain Stat5
(13), is indicated.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture. 293T cells are adenovirus-transformed human kidney epithelial cells expressing the simian virus 40 large T antigen. These cells were cultured in Dulbecco's modified Eagle medium containing 10% fetal bovine serum, 100 U of penicillin per ml, 100 µg of streptomycin per ml, and 2 mM glutamine.
Expression and purification of recombinant Stat5 proteins. A cDNA fragment encoding human Stat5a (18) was cloned between the SacI and XmaI sites of the baculovirus transfer vector pBacPAK8 (Clontech). The Stat5a W37A mutant was generated by site-directed mutagenesis (MORPH site-specific plasmid DNA mutagenesis kit; 5'-3' Inc.) and confirmed by DNA sequencing. Human Stat5b (18) was cloned between the EagI and EcoRI sites of the baculovirus transfer vector pVL1392 (PharMingen). Stat5a, Stat5a W37A, and Stat5b constructs were engineered to encode a six-histidine tag at the N terminus, following the third amino acid. Stat5-expressing viruses were generated by transfecting Sf9 cells with the pBacPAK8 or pVL1392 constructs by using the BaculoGold kit. Recombinant proteins were expressed in High Five cells (Invitrogen) that were grown in suspension in Sf900 medium (Gibco BRL). Cells were infected at a multiplicity of infection of 5:1 and harvested at 66 h postinfection. The recombinant proteins were purified by Ni2+ affinity chromatography, essentially as previously described for Stat6 (27). Proteins were eluted with concentrations of imidazole between 70 and 150 mM and quantified by the Bio-Rad protein assay kit. The wild-type Stat5a and Stat5b proteins were expressed at approximately 20 mg/109 cells and purified to approximately 90% homogeneity, as judged by Coomassie blue staining. For unknown reasons, expression of the Stat5a W37A-mutated protein was lower, although similar amounts of Stat5a and Stat5a W37A proteins were added in each experiment. Unexpectedly, Stat5a, Stat5b, and Stat5a W37A were tyrosine phosphorylated, as shown by Western blotting with PY20 and by the proteins' ability to bind DNA, suggesting that the insect cells contained an endogenous kinase capable of phosphorylating tyrosine 694 of Stat5a and tyrosine 699 of Stat5b. Coinfection with Jak1- or Jak3-encoding baculoviruses did not further increase levels of phosphorylation.
Nuclear extracts and electrophoretic mobility shift assays (EMSAs). Nuclear extracts were prepared essentially as previously described (19). Protein concentrations were determined with the Bio-Rad protein assay kit. Binding reaction mixtures (20 µl) contained 2 to 5 µg of nuclear extracts from transfected 293T cells or various amounts of recombinant Stat5 proteins, 20,000 cpm of probe (0.1 to 0.2 ng), and 2 µg of poly(dI-dC) in 10 mM Tris HCl (pH 7.5), 10 mM HEPES, 50 mM KCl, 1.25 mM dithiothreitol, 1.1 mM EDTA, and 15% glycerol. Following incubation on ice for 30 min, DNA-protein complexes were analyzed on 6% polyacrylamide gels (59:1 acrylamide-bisacrylamide) run in Tris-borate buffer at 150 V for 2.5 h at room temperature. For DNA off-rate experiments, reaction mixtures were incubated at room temperature for 30 min and then an approximately 1,000-fold molar excess of unlabeled PRRIII oligonucleotide was added for the times indicated in Fig. 2B.
Plasmids and mutagenesis.
To construct the expression
plasmids pCI-Stat5a and pCI-Stat5b, a SalI fragment
containing the full-length Stat5a-coding region was cloned in the
SalI site of pCI (Promega) and a SmaI fragment containing the full-length Stat5b cDNA from pSX-Stat5b (18) was cloned in the SmaI site of pCI. The correct orientations
of both inserts were confirmed by restriction enzyme digests.
PRRIII-E1B-luciferase was constructed by first inserting the PRRIII
sequence (13) between the XhoI and
SmaI sites of the pGL2-luciferase basic reporter plasmid
(Promega Corp.). An oligonucleotide containing the minimal E1B promoter
sequence (AGATCTGGGTATATAATAAGCTT) was then
inserted downstream of PRRIII and between the BglII and
HindIII sites immediately upstream of the luciferase
gene. The mutant plasmids pCI-Stat5a W37A, pCI-Stat5b W37A,
pCI-Stat5a W37A,K70A, pCI-Stat5b W37A,K70A, pCI-Stat5a K70A, and
pCI-Stat5b K70A were generated by performing site-directed mutagenesis
on the wild-type Stat5a and Stat5b plasmids with the kit from 5'-3'
Inc. All mutations were verified by sequence analysis. pME18S-IL-2R
,
pME18S-
c, and pME18S-Jak3 were previously described
(24, 26).
Transfections and reporter assays.
293T cells were
transfected by the calcium phosphate method. In reporter assays, cells
were transfected with 1 µg of the reporter plasmid,
PRRIII-E1B-luciferase, 25 or 50 ng of each Stat5 expression plasmid
(pCI-Stat5a and pCI-Stat5b), 2 µg of pME18S-IL-2R
, 500 ng of
pME18S-
c, 250 ng of pME18S-Jak3, and 0.5 ng of the
transfection control reporter plasmid, pRL-TKLuciferase (Promega
Corp.). Twenty-four hours after transfection, cell cultures were split
into two sets, and one set of cells was treated with 2 to 4 nM IL-2 for
14 to 16 h while the other set was left untreated. Dual luciferase
assays were performed according to the manufacturer's protocol
(Promega Corp.). All transfection experiments were performed in
triplicate, and the data are presented as the means ± standard
deviations. In transfections for EMSAs, 0.5 µg of each Stat5
expression plasmid was used to enhance the signal, and stimulation with
2 nM IL-2 was performed for 30 min. Nuclear extracts and EMSAs were
then performed as described above.
| |
RESULTS |
|---|
|
|
|---|
PRRIII exhibits much higher Stat5 DNA binding activity than either of the individual GAS motifs within PRRIII. We previously demonstrated that neither GASc nor GASn motifs derived from PRRIII (Fig. 1A) can activate transcription when cloned upstream of a heterologous promoter (13). To determine if Stat5 proteins could bind to these GAS motifs, we performed EMSAs with oligonucleotides comprising GASc, GASn, or GASc+n or full-length PRRIII and nuclear extracts prepared from PBL that were preactivated with phytohemagglutinin, rested, and then either stimulated with IL-2 or left untreated (Fig. 1B). Preactivation of cells ensured that they were primed to be maximally responsive to IL-2 treatment. Consistent with the inability of these isolated GAS motifs to activate transcription, inducible Stat5 binding to GASc or GASn probes was not discernible (Fig. 1, lanes 1 to 4) indicating that neither site alone is of sufficiently high affinity to efficiently bind Stat5 proteins present in these nuclear extracts. With long exposure times, weak binding of Stat5 was detectable with the GASc probe (data not shown). However, IL-2-induced Stat5 DNA binding activity was readily detected with a probe spanning both GAS motifs (Fig. 1, lane 6), suggesting that activation of PRRIII may depend on the ability of Stat5 proteins to bind synergistically to the tandem GAS motifs. Interestingly, Stat5 binding to full-length PRRIII was greater than that observed with the GASc+n probe (Fig. 1, lane 8 versus 6), suggesting that other proteins that bind to PRRIII may additionally stabilize Stat5 binding to PRRIII.
Stat5 binds to PRRIII as a tetramer. To further analyze the requirements for Stat5 tetramerization and thus for binding to PRRIII, we constructed putative N-terminal oligomerization mutants of Stat5, based on the crystal structure of the N domain of Stat4 (31). Tryptophan 37 (W37) is the key residue at the heart of the polar interaction interface in N-terminally oligomerized Stat4 and is important for gamma interferon-stimulated gene activation in vivo (31). Because this residue is conserved in all STAT proteins, we substituted an alanine in that location in both Stat5a and Stat5b. Additionally, glutamic acid 66 (E66) in Stat4 was shown to make direct and water-mediated contacts with W37 (31). Therefore, we sought to evaluate the importance of the correspondingly positioned lysine 70 residue in Stat5a and Stat5b. Thus, both W37 and K70 were replaced with alanine residues individually and in combination in both Stat5a and Stat5b.
To verify that Stat5 bound as a tetramer to PRRIII and that mutations of W37 could abolish tetramer formation, we generated wild-type (rStat5a) and W37A mutant Stat5a (rStat5a W37A) proteins using a baculovirus expression system. EMSAs were first performed with these purified recombinant proteins and a 32P-labeled GASc probe (Fig. 2A, lanes 1 and 2). Although little if any binding of Stat5 proteins to GASc was detected from nuclear extracts (Fig. 1, lane 2), purified Stat5 protein bound to this probe (Fig. 2A, lane 1), indicating that this site functions as a consensus GAS motif when sufficient amounts of Stat5 protein are added. Purified rStat5a W37A protein formed a dimeric complex that comigrated with and was similar in intensity to the major complex obtained with wild-type rStat5a (Fig. 2A, lane 2 versus 1); thus, as expected, the W37A mutation did not diminish the rates of Stat5a binding as a dimer. We next analyzed the complexes that these purified proteins formed with a 32P-labeled PRRIII probe containing two tandem GAS motifs (Fig. 2A, lanes 3 and 4). Binding of purified rStat5a produced a major low-mobility band (Fig. 2A, lane 3), which presumably corresponds to two Stat5 dimers bound in a tetrameric complex, as well as a weaker, faster-migrating band, which, after normalization for the fact that the PRRIII probe is longer than the GASc probe, presumably represents a single dimer bound to DNA, similar to that seen in lanes 1 and 2 of Fig. 2A. In contrast to rStat5a, the purified rStat5a W37A protein primarily formed the dimer-DNA complex with greater mobility (Fig. 2A, lane 4). Taken together, these results suggest that Stat5a binds to PRRIII predominantly as a tetramer and that the formation of this complex is mediated through protein-protein interactions involving W37 in the N domain of Stat5a.
|
Stat5 tetramer formation is important for transcriptional
activation of PRRIII.
We next assessed the in vivo importance of
Stat5 tetramer formation in IL-2-induced PRRIII activation using an
IL-2R reconstitution system in 293T cells (37). 293T cells
were transfected with expression vectors encoding IL-2R
,
c, Jak3, and either wild-type Stat5a or Stat5b or mutant
versions of these proteins. Nuclear extracts were prepared from these
transfections, and the relative expressions of the wild-type or mutant
Stat5a and Stat5b proteins are shown in Fig.
3A. EMSAs were performed using these
nuclear extracts and a 32P-labeled PRRIII probe (Fig. 3B).
We observed a low level of constitutive Stat5 binding in the absence of
IL-2 treatment in transfected 293T cells. This is consistent with our
finding that there is a low level of constitutive tyrosine
phosphorylation of overexpressed Stat5 proteins in these cells
(possibly due to the high levels of activated Jak1 kinase in these
cells [unpublished observations]). Nevertheless, IL-2 greatly
enhanced the formation of an inducible complex when wild-type Stat5a or
Stat5b was transfected either alone or in combination (Fig. 3B, lanes
2, 10, and 18); the complex formed in each case was a single, slowly
migrating band indicative of tetramer formation. Interestingly, Stat5a
reproducibly exhibited higher DNA binding activity to PRRIII than did
Stat5b (Fig. 3B, lane 2 versus 10). As expected, the W37A mutants of
both Stat5a and Stat5b exhibited only very low levels of tetrameric
complex formation (Fig. 3B, lanes 4 and 12 versus 2 and 10). The K70A mutant also showed a decreased level of complex formation (Fig. 3B,
lanes 6 and 14), while the simultaneous mutation of W37 and K70
virtually abrogated the binding of Stat5a and Stat5b proteins to PRRIII
(Fig. 3B, lanes 8 and 16). Additionally, coexpression of the W37A-K70A
doubly mutated versions of Stat5a and Stat5b resulted in no DNA binding
activity (Fig. 3B, lane 20). We hypothesize that the presence of
tetrameric, rather than dimeric, mutant protein complexes could be due
to heterodimerization of the mutant Stat5 proteins with endogenous
wild-type Stat5 proteins.
|
|
Stat5 dimers can activate a PRRIII mutant containing high-affinity GAS motifs. The above results demonstrate the importance of N-domain-mediated tetramer formation for Stat5 binding and consequently for IL-2-induced PRRIII activation. We therefore hypothesized that augmenting the affinity of the GAS motifs in PRRIII might eliminate the requirement for Stat5 tetramer formation for maximal transcriptional activation. We initially mutated the GASn motif into a consensus site (Fig. 5A, mutant M9) so that both GAS motifs in this mutant PRRIII could potentially bind dimers of Stat5 independently. 293T cells were then transfected with the IL-2 receptor components and Jak3, together with an M9-luciferase reporter construct. As expected, IL-2-induced activation of this reporter by wild-type Stat5 proteins was modestly higher than that obtained with the wild-type PRRIII reporter plasmid (Fig. 4B versus 5B; also data not shown). Interestingly, the Stat5 W37A mutants did not maximally activate this reporter (Fig. 5B), suggesting that N-domain-mediated tetramer formation of Stat5 proteins is required for binding to the two GAS motifs in this mutant PRRIII sequence. Consistent with this finding, in EMSAs, Stat5 protein from transfected 293T nuclear extracts bound to M9 only as a tetramer and similarly produced Stat5 W37A mutant protein bound much less efficiently to this probe (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we have directly demonstrated the importance of the
tetramerization of Stat5 for IL-2-induced regulation of the IL-2
response element (PRRIII) in the human IL-2R
gene. This extends the
work of Meyer et al., who provided evidence that Stat5 could form
oligomeric complexes on the murine IL-2R
gene but did not directly
establish the importance of N-domain-mediated tetramer formation for
IL-2-induced transcriptional activation (20). Our study is
based on the crystal structure of the Stat4 N domain and the
description of the interface between N domains (31). We
describe the first testing of the predictions from this structure
concerning STAT oligomerization in the context of the transcriptional
regulation of a "natural" promoter.
PRRIII is a composite element whose full functional activity requires
two tandemly linked GAS motifs and a juxtaposed Ets binding site
(13, 15, 29). Based on our ability to detect physiological
levels of Stat5 binding only when both GAS motifs from PRRIII were
present (13) (Fig. 1), we speculated that binding to these
sites was dependent on synergistic interactions between two Stat5
dimers. In their study of the IL-2 response element in the murine
IL-2R
promoter, Meyer et al. demonstrated the formation of a
lesser-mobility complex that corresponds to a Stat5 tetramer. Surprisingly, however, the higher-mobility, dimeric Stat5 complex was
often detected as the favored form, and the lesser-mobility complex was
detected even when only a single GAS motif was present in the probe
(20). In contrast, we show that in the human IL-2R
promoter, cooperative Stat5 binding uniformly results in the formation of a stable tetramer (Fig. 2B). Moreover, we demonstrate that mutation
of W37 in Stat5 (which is required for N-domain-mediated tetramerization of Stat1) (31) substantially decreased
tetrameric Stat5 complex formation and concomitantly decreased
IL-2-induced transcriptional activation of PRRIII, thus directly
linking tetramerization to IL-2 responsiveness.
In addition to W37, we studied the importance of another residue, K70. K70 in Stat5 spatially corresponds to E66 of Stat4, which makes important water-mediated and direct contacts with W37 (31). We therefore speculated that K70 might make important contacts with W37 in Stat5. Although K70 is opposite in charge to E66, both residues can form charge-stabilized hydrogen bonds which contribute to the polar hydrophilic interface described in the Stat4 structure. Thus, these two residues are functional homologues within different STATs. Interestingly, although mutation of K70 substantially diminished Stat5 DNA binding activity, the K70A mutants of Stat5a and Stat5b retained somewhat more binding activity than the W37A mutants (Fig. 3B and data not shown). It is well established that individual residues in a protein-protein interface contribute to varying extents to the overall binding energy (34); therefore, it is not surprising that two different point mutations (such as K70A and W37A) in a complex interface of presumably approximately a dozen residues (31) differ in the severity of their effects on binding.
Although the K70A mutation had a significant effect on binding (Fig. 3), it had no obvious effect on transcriptional activation in the 293T overexpression-reconstitution system (Fig. 4). This presumably indicates that sufficient tetramer formation can occur in these cells to allow this effect. This may result in part from dimerization with endogenous wild-type Stat5 in 293T cells and could reflect a greater level of homo- or heterodimerization of Stat5 K70 mutants in vivo than could be detected under the in vitro experimental conditions of EMSAs. The fact that the mutation of both W37 and K70 most dramatically diminished both Stat5 DNA binding and transactivation strongly suggests that both residues are required for efficient tetramerization of Stat5.
This study demonstrates that dimeric Stat5 is not competent to be the
transcriptionally active molecule for all Stat5-responsive promoters
and that further oligomerization (e.g., tetramerization in the case of
the IL-2R
promoter) is absolutely required for the activation of
certain genes. This pivotal role of higher-order aggregates in the
activation of promoters with multiple, weak STAT binding sites is
demonstrated in Fig. 5. This experiment shows that attenuated
protein-protein interactions can be compensated for by increased
protein-DNA binding strength. Conversely, N-domain-mediated oligomerization enables Stat5 to extend its range of target sites considerably by virtue of additionally utilizing nonconsensus sites for
binding. Thus, dimeric, but tetramerization-deficient, STATs have a
more limited set of binding sites than do tetramerization-competent STATs.
At present it is unclear how the ability of STATs to form higher-order oligomers is linked to promoter selectivity. Xu et al. (35) have shown differential binding site occupancy by oligomerized STATs and suggest that this phenomenon reflects binding site preferences. In this regard, we were unable to achieve stable binding of dimeric Stat5 to the M9 mutant PRRIII sequence that converts the GASn to a consensus GAS by a point mutation to change TTCTGATAA to TTCTGAGAA. Instead, to achieve high-affinity binding, we made additional changes in the nucleotides in the central GASn core and in the sequences immediately flanking both the GAS motifs (mutant M10) in accordance with a binding site selection analysis performed with recombinant Stat5 proteins (28a). This result suggests that the affinity of binding of Stat5 proteins to a given GAS element can be influenced not only by the central three nucleotides within the core GASc motif but also by the surrounding nucleotides.
In conclusion, we have demonstrated that tetramerization of Stat5 is essential for the potent transcriptional regulation of PRRIII. This finding is presumably relevant for other Stat5-dependent genes whose promoters contain tandem GAS motifs. Indeed, based on the absolute conservation of W37 in all known STAT proteins (31), it seems likely that N-domain-mediated tetramerization is a mechanism commonly used by these proteins. Our data demonstrate that Stat5 W37A can bind as a dimer and mediate transcriptional activation of tandem high-affinity sites (e.g., the PRRIII M10 mutant [Fig. 5E]), but it is incapable of potently activating the wild-type PRRIII sequence. The ability of wild-type STAT proteins to form tetramers enables these proteins to achieve stable binding to tandem weak sites, such as those found in PRRIII, thus extending the repertoire of putative binding sites. This underscores the role of tetramerization in selective activation of tandem GAS motifs to mediate gene-specific activation. Finally, the fact that STAT proteins have been reported to interact with other transcription factors (reviewed in references 9 and 16) whose binding sites are juxtaposed may be another mechanism that allows a gene to achieve maximal transcriptional activation in response to specific external stimuli.
| |
ACKNOWLEDGMENTS |
|---|
We thank Jian-Xin Lin and Ming-hua Zhu for critical comments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg. 10, Rm. 7N252, 10 Center Dr., Bethesda, MD 20892-1674. Phone: (301) 496-0098. Fax: (301) 402-0971. E-mail: wjl{at}helix.nih.gov.
Present address: Forschungsinstitut für Molekulare
Pharmakologie, Arbeitsgruppe Zellulare Signalverarbeitung, 10315 Berlin, Germany.
Present address: IRIS, Chiron Brocine, 53100 Siena, Italy.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Beadling, C.,
D. Guschin,
B. A. Witthuhn,
A. Ziemiecki,
J. N. Ihle,
I. M. Kerr, and D. A. Cantrell.
1994.
Activation of JAK kinases and STAT proteins by interleukin-2 and interferon , but not the T cell antigen receptor, in human T lymphocytes.
EMBO J.
13:5606-5615.
|
| 2. |
Boussiotis, V. A.,
D. L. Barber,
T. Nakarai,
G. J. Freeman,
J. G. Gribben,
G. M. Bernstein,
A. D. d'Andrea,
J. Ritz, and L. M. Nadler.
1994.
Prevention of T cell anergy by signaling through the c chain of the IL-2 receptor.
Science
266:1039-1042 |
| 3. |
Darnell, J. E., Jr.
1997.
STATs and gene regulation.
Science
277:1630-1635 |
| 4. | Decker, T., P. Kovarik, and A. Meinke. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J. Interferon Cytokine Res. 17:121-134[Medline]. |
| 5. |
Fujii, H.,
Y. Nakagawa,
U. Schindler,
A. Kawahara,
H. Mori,
F. Gouilleux,
B. Groner,
J. N. Ihle,
Y. Minami,
T. Miyazaki, and T. Taniguchi.
1995.
Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor chain but is not essential for the proliferative signal transmission.
Proc. Natl. Acad. Sci. USA
92:5482-5486 |
| 6. |
Gaffen, S. L.,
S. Y. Lai,
W. Xu,
F. Gouilleux,
B. Groner,
M. A. Goldsmith, and W. C. Greene.
1995.
Signaling through the interleukin 2 receptor chain activates a STAT-5-like DNA-binding activity.
Proc. Natl. Acad. Sci. USA
92:7192-7196 |
| 7. |
Gilmour, K.,
R. Pine, and N. C. Reich.
1995.
Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.
Proc. Natl. Acad. Sci. USA
92:10772-10776 |
| 8. |
Horvath, C. M.,
Z. Wen, and J. E. Darnell, Jr.
1995.
A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain.
Genes Dev.
9:984-994 |
| 9. | Horvath, C. M., and J. E. Darnell, Jr. 1997. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:233-239[Medline]. |
| 10. | Hou, J., U. Schindler, W. J. Henzel, S. C. Wong, and S. L. McKnight. 1995. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 2:321-329[Medline]. |
| 11. | Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334[Medline]. |
| 12. |
Imada, K.,
E. T. Bloom,
H. Nakajima,
J. A. Horvath-Arcidiacono,
G. B. Udy,
H. Davey, and W. J. Leonard.
1998.
Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.
J. Exp. Med.
188:2067-2074 |
| 13. |
John, S.,
C. M. Robbins, and W. J. Leonard.
1996.
An IL-2 response element in the human IL-2 receptor chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein.
EMBO J.
15:5627-5635[Medline].
|
| 14. | Johnston, J. A., M. Kawamura, R. A. Kirken, Y. Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151-153[Medline]. |
| 15. |
Lécine, P.,
M. Algarté,
P. Rameil,
C. Beadling,
P. Bucher,
M. Nabholz, and J. Imbert.
1996.
Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor gene.
Mol. Cell. Biol.
16:6829-6840[Abstract].
|
| 16. | Leonard, W. J., and J. J. O'Shea. 1998. Jaks and STATs: biological implications. Annu. Rev. Immunol. 16:293-322[Medline]. |
| 17. | Lin, J.-X., and W. J. Leonard. 1997. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 8:313-332[Medline]. |
| 18. |
Lin, J. X.,
J. Mietz,
W. S. Modi,
S. John, and W. J. Leonard.
1996.
Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
J. Biol. Chem.
271:10738-10744 |
| 19. | Lin, J.-X., T.-S. Migone, M. Tsang, M. Friedmann, J. A. Weatherbee, L. Zhou, A. Yamauchi, E. T. Bloom, J. Mietz, S. John, and W. J. Leonard. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339[Medline]. |
| 20. |
Meyer, W. K.,
P. Reichenbach,
U. Schindler,
E. Soldaini, and M. Nabholz.
1997.
Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription.
J. Biol. Chem.
272:31821-31828 |
| 21. | Mikita, T., D. Campbell, P. Wu, K. Williamson, and U. Schindler. 1996. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol. Cell. Biol. 16:5811-5820[Abstract]. |
| 22. |
Miyazki, T.,
A. Kawahara,
H. Fujii,
Y. Nakagawa,
Y. Minami,
Z.-J. Liu,
I. Oishi,
O. Silvennoinen,
B. A. Witthuhn,
J. N. Ihle, and T. Taniguchi.
1994.
Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.
Science
266:1045-1047 |
| 23. |
Nakajima, H.,
X. Liu,
A. Wynshaw-Boris,
L. A. Rosenthal,
K. Imada,
D. S. Finbloom,
L. Hennighausen, and W. J. Leonard.
1997.
An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor chain induction.
Immunity
7:691-701[Medline].
|
| 24. |
Nakamura, Y.,
S. M. Russell,
S. A. Mess,
M. Friedmann,
M. Erdos,
C. Francois,
Y. Jacques,
S. Adelstein, and W. J. Leonard.
1994.
Heterodimerization of the IL-2 receptor - and -chain cytoplasmic domains is required for signalling.
Nature
396:330-333.
|
| 25. | Nielsen, M., A. Svejgaard, S. Skov, and N. Odum. 1994. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of Stat3 in human T lymphocytes. Eur. J. Immunol. 24:3082-3086[Medline]. |
| 26. |
Russell, S. M.,
J. A. Johnston,
M. Noguchi,
M. Kawamura,
C. M. Bacon,
M. Friedmann,
M. Berg,
D. W. McVicar,
B. A. Witthuhn,
O. Silvennoinen,
A. S. Goldman,
F. C. Schmalstieg,
J. N. Ihle,
J. J. O'Shea, and W. J. Leonard.
1994.
Interaction of IL-2R and c chains with Jak1 and Jak3: implications for XSCID and XCID.
Science
266:1042-1045 |
| 27. | Schindler, U., P. Wu, M. Rothe, M. Brasseur, and S. L. McKnight. 1995. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2:689-697[Medline]. |
| 28. |
Seidel, H. M.,
M. H. Lawrence,
P. Lamb,
J. E. Darnell, Jr.,
R. B. Stein, and J. Rosen.
1995.
Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity.
Proc. Natl. Acad. Sci. USA
92:3041-3045 |
| 28a. | Soldaini, E. Unpublished data. |
| 29. |
Sperisen, P.,
S. M. Wang,
E. Soldaini,
M. Pla,
C. Rusterholz,
P. Bucher,
P. Corthesy,
P. Reichenbach, and M. Nabholz.
1995.
Mouse interleukin-2 receptor gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements.
J. Biol. Chem.
270:10743-10753 |
| 30. |
Vinkemeier, U.,
S. L. Cohen,
I. Moarefi,
B. T. Chait,
J. Kuriyan, and J. E. Darnell, Jr.
1996.
DNA binding of in vitro activated Stat1 , Stat1 and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites.
EMBO J.
15:5616-5626[Medline].
|
| 31. |
Vinkemeier, U.,
I. Moarefi,
J. E. Darnell, Jr., and J. Kuriyan.
1998.
Structure of the amino-terminal protein interaction domain of Stat4.
Science
279:1048-1052 |
| 32. | Wakao, H., N. Harada, T. Kitamura, A. L. Mui, and A. Miyajima. 1995. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J. 14:2527-2535[Medline]. |
| 33. | Witthuhn, B. A., O. Silvennoinen, O. Miura, K. S. Lai, C. Cwik, E. T. Liu, and J. N. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153-157[Medline]. |
| 34. | Xu, D., S. L. Lin, and R. Nussinov. 1997. Protein binding versus protein folding: the role of hydrophilic bridges in protein associations. J. Mol. Biol. 265:68-84[Medline]. |
| 35. | Xu, X., Y.-L. Sun, and T. Hoey. 1996. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794-797[Abstract]. |
| 36. | Yan, R., S. Small, C. Desplan, C. R. Dearolf, and J. E. Darnell, Jr. 1996. Identification of a Stat gene that functions in Drosophila development. Cell 84:421-430[Medline]. |
| 37. |
Zhu, M.-H.,
J. A. Berry,
S. M. Russell, and W. J. Leonard.
1998.
Delineation of the regions of interleukin-2 (IL-2) receptor chain important for association of Jak1 and Jak3.
J. Biol. Chem.
273:10719-10725 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»